Prospective evaluation of retinal toxicity of platinum-based chemotherapy in patients with testicular cancer (RETOX-study)
Not Applicable
Recruiting
- Conditions
- C62S04.0Malignant neoplasm of testisInjury of optic nerve and pathways
- Registration Number
- DRKS00016166
- Lead Sponsor
- gOA Uniklinik Frankfurt
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 72
Inclusion Criteria
patients diagnosed with testicular cancer
- indication for platinum-based chemotherapy according to current guidelines
- legal age
- written consent
Exclusion Criteria
- any kind of eye-disease
- minority (nonage)
- ongoing legal care
- prior chemotherapy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Retinal alterations one months upon completion of platinum-based chemotherapy, defined as alterations of the retinal nerve fiber thickness in µm
- Secondary Outcome Measures
Name Time Method